Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.21% |
| 2 | Technology | 11.19% |
| 3 | Healthcare | 7.18% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Financials | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Rekor Systems
REKR
$79M
| $972K | ﹤0.01% |
+120,444
| New | +$658K |
|
|
GBIO
3702
DELISTED
Generation Bio
GBIO
| $971K | ﹤0.01% |
+3,426
| New | +$1.1M |
|
|
CMLS
3703
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $970K | ﹤0.01% |
111,228
-49,568
| -31% | -$348K |
|
|
VVNT
3704
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $969K | ﹤0.01% |
46,685
-99,481
| -68% | -$1.98M |
|
3705
Lamar Advertising Co
LAMR
$15.3B
| $965K | ﹤0.01% |
11,595
-88,237
| -88% | -$6.6M |
|
3706
Power Integrations
POWI
$3.09B
| $965K | ﹤0.01% |
11,792
-1,976
| -14% | -$134K |
|
3707
SITE Centers
SITC
$156M
| $965K | ﹤0.01% |
122,161
-272,594
| -69% | -$1.9M |
|
3708
CleanSpark
CLSK
$3.33B
| $964K | ﹤0.01% |
+33,201
| New | +$423K |
|
|
ITMR
3709
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $963K | ﹤0.01% |
48,489
+25,139
| +108% | +$502K |
|
|
ARD
3710
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $963K | ﹤0.01% |
55,977
+19,316
| +53% | +$321K |
|
3711
Franklin Covey
FC
$230M
| $962K | ﹤0.01% |
+43,182
| New | +$898K |
|
3712
AstraZeneca
AZN
$255B
| $961K | ﹤0.01% |
9,611
-92,475
| -91% | -$9.79M |
|
|
SMTX
3713
DELISTED
SMTC Corporation
SMTX
| $959K | ﹤0.01% |
193,404
-92,901
| -32% | -$385K |
|
3714
CALL
Tandem Diabetes Care
TNDM
$1.49B
| $957K | ﹤0.01% |
+10,000
| New | +$1.03M |
|
3715
PUT
Hormel Foods
HRL
$11.7B
| $956K | ﹤0.01% |
20,500
| – | – |
|
3716
NextCure
NXTC
$27.6M
| $956K | ﹤0.01% |
7,312
-33,909
| -82% | -$4.38M |
|
3717
Vanguard High Dividend Yield ETF
VYM
$82.9B
| $956K | ﹤0.01% |
10,451
+1,525
| +17% | +$132K |
|
|
LNW
3718
PUT
DELISTED
Light & Wonder
LNW
| $954K | ﹤0.01% |
+23,000
| New | +$847K |
|
3719
Usana Health Sciences
USNA
$261M
| $952K | ﹤0.01% |
12,345
-47,554
| -79% | -$3.68M |
|
|
XNET
3720
Xunlei
XNET
$319M
| $952K | ﹤0.01% |
+329,243
| New | +$963K |
|
3721
Minerva Neurosciences
NERV
$245M
| $951K | ﹤0.01% |
50,818
+40,791
| +407% | +$1.03M |
|
3722
ADC Therapeutics
ADCT
$143M
| $950K | ﹤0.01% |
29,679
-2,068
| -7% | -$67.8K |
|
3723
United Natural Foods
UNFI
$2.86B
| $950K | ﹤0.01% |
59,501
-157,427
| -73% | -$2.63M |
|
3724
Clearfield
CLFD
$407M
| $945K | ﹤0.01% |
+38,242
| New | +$895K |
|
|
AGC
3725
CALL
DELISTED
Altimeter Growth Corp
AGC
| $945K | ﹤0.01% |
+73,491
| New | +$940K |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $25B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.